Skip to content

Sleep Disorders Reference

Sleep disorders are conditions that alter the timing, continuity, depth, regulation, breathing, movement, or restorative value of sleep. They include insomnia disorders, sleep-related breathing disorders, central disorders of hypersomnolence, circadian-rhythm sleep-wake disorders, parasomnias, and sleep-related movement disorders.

Sleep symptoms can also occur within another illness without becoming a separate diagnosis. Nightmares and hypervigilance may accompany post-traumatic stress disorder; decreased need for sleep can occur during mania; unrefreshing sleep is a core feature of ME/CFS; pain can repeatedly interrupt sleep; and caregiving or unsafe living conditions can produce severe sleep loss. Assessment distinguishes the symptom, the cause, and any coexisting sleep disorder instead of assuming that one label explains every form of exhaustion.

Sleepiness, fatigue, and unrefreshing sleep are related but not interchangeable. Sleepiness is a tendency to fall asleep. Fatigue may involve low physical or cognitive energy without an ability to sleep. Unrefreshing sleep describes waking without the expected restoration even after substantial sleep time. One person can experience all three.

Insomnia and Sleep-Wake Disruption

Insomnia involves persistent difficulty falling asleep, staying asleep, or returning to sleep, or waking earlier than intended, together with daytime consequences despite adequate opportunity for sleep. Short-term insomnia can follow illness, grief, trauma, pain, environmental disruption, travel, medication changes, or acute stress. Chronic insomnia persists beyond the immediate disruption and can become self-reinforcing even after the original trigger changes.

Daytime effects may include slowed processing, poor concentration, irritability, reduced frustration tolerance, headache, pain amplification, impaired coordination, and greater difficulty managing medication, nutrition, communication, or mobility. These effects do not establish the cause. A clinician reviews sleep opportunity, timing, substances, medication, pain, breathing symptoms, mood, neurological events, and the sleeping environment.

Cognitive behavioral therapy for insomnia, or CBT-I, is the usual first-line treatment for chronic insomnia. It combines condition-specific behavioral and cognitive methods rather than generic advice to “sleep better.” Standard components may require adaptation for people who are bedbound, need daytime rest, work nights, have bipolar disorder, live with pain, depend on caregivers, or use the bed for medical care and daily activity.

Medication can be useful in selected cases, but choice depends on age, respiratory status, fall risk, pregnancy, substance-use history, psychiatric condition, seizure disorder, other medication, and the pattern being treated. A medicine that helps sleep onset can still worsen breathing, balance, cognition, or morning function.

Trauma, Nightmares, and Safety During Sleep

Insomnia and nightmares are common in PTSD. Hypervigilance can make the loss of awareness involved in sleep feel unsafe, while sounds, touch, confinement, pain, or waking disorientation can reproduce elements of the original trauma. A nightmare may be recurrent or variable, literal or symbolic, and remembered clearly or only through the physical distress that follows it.

CBT-I can treat chronic insomnia in people with PTSD. Nightmare-focused care may include imagery rehearsal or other trauma-informed approaches, while medication decisions remain individualized because evidence and tolerability vary. Treatment does not require forcing a detailed retelling of the dream, removing practical safety measures before trust exists, or treating a person’s need for light, sound, proximity, or predictable check-ins as irrational.

The sleeping environment matters. A person who has experienced institutional restraint, assault, medical crisis, gun violence, or unpredictable intrusion may need control over doors, lighting, touch, room access, alarms, and who may wake them. Those arrangements can coexist with therapy and can change over time.

Sleep apnea causes repeated reductions or pauses in breathing during sleep. The interruptions can fragment sleep, lower oxygen, raise carbon dioxide in some conditions, and increase cardiovascular and daytime burden. Loud snoring, witnessed pauses, gasping, morning headache, dry mouth, frequent waking, nocturia, and excessive daytime sleepiness are possible signs, but none appears in every person. Snoring alone does not establish apnea, and absence of loud snoring does not exclude central events.

Obstructive Sleep Apnea

In obstructive sleep apnea, the upper airway narrows or closes while respiratory effort continues. Anatomy, muscle tone, sleep stage, sleeping position, nasal obstruction, enlarged tonsils or adenoids, endocrine conditions, medication, alcohol, and body composition can contribute. Obesity is an important risk factor but is neither necessary nor sufficient; a thin person can have OSA, and weight does not identify severity by itself.

People with Down syndrome have a high rate of OSA because several airway and muscle-tone factors can overlap. A familiar lifelong pattern of snoring, daytime sleepiness, changed communication, reduced participation, or difficult behavior still requires clinical evaluation rather than being assigned automatically to Down syndrome, intellectual disability, aging, or personality.

Central Sleep Apnea and Coexisting Events

In central sleep apnea, airflow stops because respiratory effort is absent or reduced during the event. Causes and contexts include heart failure, medication or substance effects, high altitude, neurological or other medical conditions, and treatment-emergent central apnea. The mechanism and treatment depend on the clinical setting; central apnea is not simply a more severe form of OSA.

A sleep study can document both central and obstructive events in one person. Individual events may also contain central and obstructive components and be scored as mixed apneas. The terms ‘’mixed apnea’‘, ‘’coexisting central and obstructive sleep apnea’‘, and ‘’treatment-emergent central sleep apnea’’ describe related but not identical findings, so the report and clinical history determine what is meant.

Evaluation

Overnight polysomnography records breathing effort, airflow, oxygenation, heart rate, sleep stage, movement, and other signals. Home sleep apnea testing can diagnose OSA in selected uncomplicated adults with a sufficiently high clinical likelihood, but it does not replace polysomnography when a result is negative or inconclusive or when central events, hypoventilation, significant cardiorespiratory disease, neuromuscular weakness, chronic opioid use, prior stroke, or severe insomnia complicate the question.

An apnea-hypopnea index summarizes scored breathing events per hour, but the number is interpreted alongside oxygen burden, carbon-dioxide retention, arousals, sleep stage and position, symptoms, comorbidity, and recording method. A single threshold does not describe every person’s functional impact or treatment need.

Treatment and Equipment

Positive airway pressure, or PAP, delivers pressurized air through a mask or other interface. CPAP supplies one continuous pressure; auto-adjusting PAP changes pressure within a prescribed range; bilevel PAP uses different inspiratory and expiratory pressures; and adaptive servo-ventilation varies support in response to breathing. Device selection follows the diagnosed pattern, titration findings, respiratory physiology, cardiac status, tolerance, and current guidance. A mixed pattern does not by itself establish one particular machine for life.

Mask fit, humidification, nasal symptoms, skin injury, sensory tolerance, dexterity, cognition, electricity, replacement supplies, cleaning access, travel, and caregiver support all affect whether treatment works outside the laboratory. A person who cannot tolerate one interface or setting may need refitting, desensitization while awake, pressure adjustment, a different device, or another treatment rather than being reduced to “noncompliant.”

Other OSA treatment can include positional measures, oral appliances, treatment of nasal or endocrine contributors, or surgery. Treatment of CSA addresses the underlying context when possible and may use PAP, oxygen, medication, phrenic-nerve stimulation, or another specialist-directed approach. Cardiopulmonary and neurological comorbidities remain part of device selection and follow-up.

Unrefreshing Sleep, Fatigue, and Hypersomnolence

Unrefreshing sleep is required within contemporary ME/CFS diagnostic criteria. A person may sleep for many hours and still wake without restored physical or cognitive capacity. Treating a coexisting primary sleep disorder can improve that part of the burden without curing ME/CFS or eliminating post-exertional malaise.

Fibromyalgia and chronic pain can also involve unrefreshing or fragmented sleep. Pain may delay sleep, wake the person during movement or positioning, and worsen after poor sleep. The relationship is bidirectional without making sleep loss the sole cause of the pain condition.

Excessive daytime sleepiness requires a different differential from fatigue alone. Insufficient sleep, sleep apnea, circadian disorder, medication, depression, neurological illness, and narcolepsy can all produce unintended sleep. Overnight polysomnography and a multiple sleep latency test are used for narcolepsy and other central hypersomnolence questions only after sleep schedule, medication, and untreated breathing disorders have been considered.

Epilepsy, Bipolar Disorder, and Sleep

Sleep and epilepsy interact in both directions. Sleep deprivation or disrupted sleep is a common trigger for some people; seizures, nocturnal events, postictal symptoms, and antiseizure medication can also alter sleep. A personal trigger pattern is established longitudinally rather than assumed from one seizure after a poor night.

In bipolar disorder, decreased need for sleep can be a manic symptom, while insomnia or excessive sleep can occur during depression. Decreased need is not the same as wanting sleep but being unable to obtain it: a person in mania may feel little need for sleep despite mounting impairment. Sleep change can be both an early warning sign and a consequence of an episode.

When epilepsy and bipolar disorder coexist, sleep loss can affect seizure and mood stability at the same time. Treatment planning coordinates neurological and psychiatric medication, because several medicines influence both conditions and can also change alertness, sleep architecture, or respiratory risk.

Access and Medical-System Context

Sleep symptoms are often invisible to the person experiencing them because breathing events, movement, or vocalization occur during sleep. Reports from partners, relatives, roommates, and direct-support workers can therefore be clinically important without replacing the sleeper’s own account. Audio or video recordings may help demonstrate a pattern, but consent and privacy still apply.

Diagnostic delay can follow when fatigue is attributed to laziness, depression, body size, disability, ordinary adolescence, aging, substance use, or a demanding career without adequate evaluation. Black patients, intellectually disabled patients, nonspeaking people, wheelchair users, and people with several chronic conditions can encounter symptoms being folded into an existing diagnosis rather than investigated.

Sleep laboratories and equipment services require physical and communication access. Adjustable or appropriately rated beds, transfer support, accessible bathrooms, the person’s usual mobility and communication equipment, sensory control, assistance positioning sensors, seizure precautions, and permission for a trusted support person may be necessary for a usable study. A technically complete recording obtained through inaccessible or traumatic conditions may still poorly represent ordinary sleep.

Associated Characters

Andy Davis lived with sleep apnea that remained undiagnosed through adolescence despite years of poor-quality sleep, daytime exhaustion, snoring, and witnessed breathing difficulty. He received the diagnosis in adulthood after Sarah Davis had repeatedly documented the pattern. Chronic pain, epilepsy, medication-related drowsiness, and sleep apnea contributed separate but interacting burdens.

Charlie Rivera had obstructive sleep apnea in addition to ME/CFS. His sleep studies did not identify central apnea. PAP treatment addressed airway obstruction and sleep fragmentation but did not make his sleep restorative or remove post-exertional malaise. His OSA was distinct from Logan Weston’s mixed central and obstructive pattern.

Logan’s sleep studies documented both central and obstructive events after the 2025 traumatic brain injury. PAP treatment added mask tolerance, tubing, cleaning, supplies, and follow-up to his established care. Treating the obstructive component remained clinically important after his 2058 complete-LAD myocardial infarction, while the central component required the breathing pattern and cardiac context to be managed together. Device type and settings changed with his recorded breathing pattern, cardiac status, and tolerance.

Elliot Landry had obstructive sleep apnea requiring CPAP as one complication of pituitary gigantism. His machine mysteriously stopped working while he lived with Sean Landry in 2032. Elliot strongly suspected that Sean had damaged it, but Sean denied responsibility, and the cause was never proved. Insurance barriers delayed replacement. Later care included sleep-medicine follow-up, mask and pressure management, and attention to the added respiratory risk of opioid pain medication.

Chrissie Williams and Sofia Medina lived with Down syndrome and sleep apnea. Chrissie’s apnea was untreated while she lived at Harmony House; in later adulthood, CPAP formed part of her nightly routine with Jon Williams. Sofia had obstructive sleep apnea treated with CPAP, with Claudia Medina managing the equipment and routine support.

Lizzie Henderson had Down syndrome and severe sleep-apnea symptoms, including loud, congested snoring, witnessed breathing pauses, gasping restarts, unrefreshing sleep, and profound daytime exhaustion. These symptoms went inadequately treated for years within the institution, where staff punished her for unintended sleep. Ellen Matsuda pursued a sleep study, and Michael documented symptoms and advocated with Jon for treatment. Lizzie eventually received CPAP after leaving institutional care; improved care and unrestricted rest did not remove her other illnesses or continuing support needs.

Chris Russell had loud snoring, witnessed breathing pauses, and persistent daytime exhaustion consistent with obstructive sleep apnea but never received diagnosis or treatment. Caleb Ross used CPAP during sleep. Patrick O’Shea was prescribed CPAP but rarely tolerated the mask, leaving mask access and treatment alternatives as part of his care rather than a question of willpower.

Insomnia, Trauma, and Mood

Jacob Keller had chronic insomnia dating from childhood. Sleep loss interacted with trauma, ADHD, bipolar I disorder, migraine, touring, and epilepsy; it was one of his most reliable seizure triggers and could also accompany or precede mania. His sleep-seizure-mood cycle required coordination rather than treating insomnia as an isolated habit.

Ezra Cruz experienced chronic sleep dysregulation and insomnia associated with severe ADHD, trauma, and anxiety. In adolescence and early adulthood, he used cannabis partly to force his body to settle enough to sleep. That short-term function became one strand of a wider substance-use pattern and did not resolve the underlying sleep difficulty.

Jamal Thompson developed insomnia and hypervigilance after the 2019 police violence. Several days without restorative sleep worsened his migraines and left him able to sleep deeply only after the familiar safety of Marva Thompson’s hair-braiding routine lowered his vigilance.

Brian Trevino’s PTSD involved chronic sleep disruption and insomnia that overlapped with his late-night DJ schedule. Jared Dawkins learned to distinguish Brian’s chosen wakefulness for work from nights when trauma and hypervigilance prevented sleep.

Michael Bell’s institutional trauma produced nightmares, fear of immobilization, and heightened sensitivity to locked doors, cleaning smells, fluorescent hum, and unexpected touch. Sleep care therefore depended on control, consent, predictability, and safety as well as any direct treatment of nightmares.

Unrefreshing Sleep and Excessive Sleepiness

Cody Matsuda and Charlie both lived with ME/CFS. Cody developed severe fatigue in adolescence and used flexible pacing, daytime rest, wheelchair access, and the Matsuda-Davis Homeschool Cooperative after traditional school became unsustainable. Charlie required daytime sleep by age twelve or thirteen and later structured school, touring, and creative work around rest, but sleep did not return either man to a pre-illness energy baseline.

Gavin Worth experienced unrefreshing sleep and unintended sleep as part of his fibromyalgia presentation. His workup considered his positional snoring but did not find clinically significant obstructive sleep apnea. The negative breathing study did not make the sleepiness or fatigue unreal.

Riley Mercer had narcolepsy type 1 with cataplexy. Their excessive daytime sleepiness and familiar napping belonged to a central disorder of sleep-wake regulation rather than to ME/CFS, ordinary sleep deprivation, or sleep apnea.

Sources

Medical Conditions Sleep Disorders Neurological Conditions Respiratory Conditions